avelumab
Showing 1 - 25 of 171
Avelumab in Real-World Treatment for Advanced or Metastatic
Not yet recruiting
- Bladder Cancer
- Avelumab
- (no location specified)
Nov 21, 2022
Breast Cancer Trial (Avelumab, Aspirin, Lansoprazole)
Not yet recruiting
- Breast Cancer
- Avelumab
- +2 more
- (no location specified)
Feb 2, 2023
Advanced Urothelial Carcinoma Trial in Boston (copanlisib, Avelumab)
Not yet recruiting
- Advanced Urothelial Carcinoma
- copanlisib
- Avelumab
-
Boston, MassachusettsVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Jan 13, 2023
Lymphomas Non-Hodgkin's B-Cell Trial in Ballarat, Box Hill, Heidelberg (Avelumab)
Active, not recruiting
- Lymphomas Non-Hodgkin's B-Cell
- Avelumab
-
Ballarat, Victoria, Australia
- +2 more
Jan 30, 2023
Breast Cancer Trial in Washington, Charlotte, Salt Lake City (Talazoparib, Avelumab)
Active, not recruiting
- Breast Cancer
- Talazoparib
- Avelumab
-
Washington, District of Columbia
- +1 more
Oct 10, 2022
Urothelial Carcinoma Trial in Iowa City (Avelumab, Docetaxel)
Active, not recruiting
- Urothelial Carcinoma
- Avelumab
- Docetaxel
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Oct 18, 2022
Leptomeningeal Metastases, Leptomeningeal Disease Trial in Tampa (Avelumab, Whole Brain Radiotherapy)
Active, not recruiting
- Leptomeningeal Metastases
- Leptomeningeal Disease
- Avelumab
- Whole Brain Radiotherapy
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Aug 19, 2022
Meningioma, Meningioma, Adult Trial in Saint Louis (drug, radiation, procedure)
Active, not recruiting
- Meningioma
- Meningioma, Adult
- Avelumab
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Sep 27, 2022
Sarcoma, Advanced Sarcoma, High Grade Sarcoma Trial in New York (DCC-3014, Avelumab)
Active, not recruiting
- Sarcoma
- +6 more
- DCC-3014
- Avelumab
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 26, 2022
Recurrent or Metastatic NPC Trial in Hong Kong (Axitinib, Avelumab)
Recruiting
- Recurrent or Metastatic NPC
- Axitinib
- Avelumab
-
Hong Kong, Hong KongDepartment of Clinical Oncology, Prince of Wales Hospital, The C
Jul 18, 2022
POLE Exonuclease Mutant Colon Cancer, Microsatellite Instability, Stage III Colon Cancer Trial in Sutton (Avelumab)
Terminated
- POLE Exonuclease Mutant Colon Cancer
- +2 more
- Avelumab
-
Sutton, Surrey, United KingdomRoyal Marsden NHS Foundation Trust
Oct 5, 2022
Hepatocellular Carcinoma Trial in Dallas (Axitinib, Avelumab, Bavituximab)
Not yet recruiting
- Hepatocellular Carcinoma
- Axitinib
- +2 more
-
Dallas, TexasThe University of Texas Southwestern Medical Center
Jun 27, 2022
Non Small Cell Lung Cancer, Solid Tumor Trial in Jette, Brussel (Avelumab, Ipilimumab 5 MG/ML, Pembrolizumab 100 MG in 4 ML
Recruiting
- Non Small Cell Lung Cancer
- Solid Tumor
- Avelumab
- +3 more
-
Jette, Brussels, Belgium
- +1 more
Sep 9, 2022
Metastatic Colorectal Cancer, RAS Wild Type Trial in Napoli (Avelumab, Cetuximab)
Completed
- Metastatic Colorectal Cancer
- RAS Wild Type
- Avelumab
- Cetuximab
-
Napoli, ItalyUniversità della Campania Luigi Vanvitelli
May 4, 2022
Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)
Not yet recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- Axitinib
- +2 more
-
Boston, Massachusetts
- +2 more
Jun 27, 2022
Head Neck Cancer, Squamous Cell Carcinoma Trial in London (Avelumab, Cetuximab)
Active, not recruiting
- Head and Neck Cancer
- Squamous Cell Carcinoma
- Avelumab
- Cetuximab
-
London, United KingdomUniversity College Hospital
May 17, 2022
Osteosarcoma Trial in United States (Avelumab, Questionnaires)
Active, not recruiting
- Osteosarcoma
- Avelumab
- Questionnaires
-
Los Angeles, California
- +3 more
Aug 22, 2022
OBSERVATIONAL STUDY OF AVELUMAB AS FIRST-LINE MAINTENANCE
Recruiting
- Urothelial Cancer
- Avelumab
-
Bristol, United Kingdom
- +9 more
Jan 23, 2023
Clear-Cell Renal Carcinoma Trial run by the NCI (rhIL-15, Avelumab)
Terminated
- Clear-Cell Renal Carcinoma
- rhIL-15
- Avelumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 27, 2022
Stage III Merkel Cell Carcinoma AJCC v8, Stage IIIB Merkel Cell Carcinoma AJCC v8, Stage IIIA Merkel Cell Carcinoma AJCC v8
Recruiting
- Stage III Merkel Cell Carcinoma AJCC v8
- +2 more
- Avelumab
- +2 more
-
Orange, California
- +10 more
Jan 30, 2023
Treatment Related Cancer Trial in Munich (5-FU, Folinic Acid, Irinotecan)
Active, not recruiting
- Treatment Related Cancer
- 5-FU
- +4 more
-
Munich, GermanyLudwig Maximilians University
Jan 19, 2022
And Use Of Avelumab In Combination With Axitinib For Treatment
Recruiting
- Advanced Renal Cell Carcinoma
- avelumab
- axitinib
-
Sandwich, Kent, United KingdomPfizer Ltd
May 23, 2022
SOGUG-AVELUMAB_RWD
Recruiting
- Metastatic Urothelial Carcinoma
- Avelumab
-
Vigo, Pontevedra, Spain
- +21 more
Jan 17, 2023
Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)
Recruiting
- Triple Negative Breast Cancer
- +5 more
- Palbociclib
- Avelumab
-
Manchester, Greater Manchester, United Kingdom
- +6 more
Jan 5, 2023